Jump to content

Search the Community

Showing results for tags 'Vaccines'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Discussions
    • Polio
    • Flu awareness
    • European Immunization Week, 23–29 April 2018
    • Migration and immunization
    • World Hepatitis Day, 28 July 2017
    • European Immunization Week, 24 - 30 April 2017
    • General discussions
    • Education on Immunization
    • Data visualization
    • About NITAGs
    • Research papers, articles, and reports
    • News and social media
    • Updates from partners and stakeholders
    • European Immunization Week (2016)
    • Job opportunities
    • Q&A about the site
    • Innsbruck Treffen (private forum)

Categories

  • European Immunization Week 2018
    • Planning resources - EIW 2018
    • Brochures - EIW 2018
    • Infographics - EIW 2018
    • Posters - EIW 2018
    • Banners and social media - EIW 2018
    • Meeting folders - EIW 2018
  • Flu Awareness - 2017
    • Flu Awareness Campaign Posters
  • European Immunization Week 2017
    • Planning resources - EIW 2017
    • Brochures - EIW 2017
    • Infographics - EIW 2017
    • Posters - EIW 2017
    • Banners and social media - EIW 2017
    • Meeting folders - EIW 2017
  • Flu Awareness - 2016
    • Flu Awareness Campaign Posters
  • EIW 2016
    • Planning resources
    • Posters
    • Meeting folders

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


About Me


Gender


Location


Country

Found 47 results

  1. Dear Colleagues We would like to share with you the following graphics from ECDC in support of European Immunization Week (EIW). ECDC measles infographic with updated data from 2017 PowerPoint slides with key messages on catch-up vaccination The slides can be easily translated and we are happy for you to re-use if you find the material useful. Rumila Edward and Sarah Earnshaw ECDC Measles messages.pptx Measles_2018.pdf
  2. Immunize Europe Forum

    Kак работают вакцины

    Version 1.0.0

    9 downloads

    Kак работают вакцины инфографика
  3. Immunize Europe Forum

    How vaccines work

    Version 1.0.0

    39 downloads

    EIW 2018 Infographics Vaccines English (green download button on the right) or in editable AI format (Adobe Illustrator) here: How vaccine works_EIW_2018_WHO_FINAL.ai
  4. Immunize Europe Forum

    How vaccines work

    How vaccines work
  5. Measles outbreaks continue to occur in a number of EU/EEA countries, and there is a risk of spread and sustained transmission in areas with susceptible populations. Since the beginning of 2016, 48 deaths due to measles were reported in the EU. New data published today by ECDC in the Communicable Disease Threat Report (CDTR) show that the highest number of measles cases in 2017 were reported in Romania (7 977), Italy (4 854) and Germany (904). Greece is currently experiencing a measles outbreak, with 690 cases including two deaths, reported since May 2017; most cases were unvaccinated or incompletely vaccinated. The monthly measles and rubella surveillance monitoring report is also published today and provides more in-depth analysis of the situation. The spread of measles across Europe is due to suboptimal vaccination coverage in many EU/EEA countries: of all measles cases reported during the one-year period 1 November 2016‒31 October 2017 with known vaccination status, 87% were not vaccinated. Measles increasingly affects all age groups across Europe and in 2017, 45% of measles cases with known age were aged 15 years or older. Romania, Italy, Germany and Greece were the countries most affected by measles during 2016 and 2017 and each shows different trends: Romania saw a sharp increase in cases from October 2016, and the trend has continued throughout 2017; in Italy, the increasing trend started in January 2017, while in Germany it began in February 2017; Greece has seen a measles outbreak starting in the second half of 2017, with 167 cases reported in October. This data is based on analysis of the cases notified to ECDC and included in the monthly and biannual monitoring reports. The latest available figures on vaccination coverage collected by WHO (2016) show that the vaccination coverage for the first dose of measles was below 95% in 18 of 30 EU/EEA countries; for the second dose of measles, it was below 95% in 20 of 27 EU/EEA countries reporting second dose coverage data. In order to achieve the measles elimination goal, the vaccination coverage rates for children targeted by routine vaccination programmes should increase in a number of countries, as the vaccination coverage of the second dose must be at least 95% to interrupt measles circulation and achieve herd immunity. This is particularly important to protect children below one year of age, who are particularly vulnerable to complications of measles but are too young to have received the first dose of vaccine. Read more ECDC collects measles data on a monthly basis via The European Surveillance System (TESSy). In addition, ECDC monitors measles and rubella epidemiology and outbreaks via epidemic intelligence. For a complete overview of data regarding measles outbreaks in the EU/EEA in 2016 and 2017, the following outputs are available and regularly updated: Communicable Disease Threat Report “Measles and Rubella, Monitoring European and worldwide outbreaks” (Epidemic intelligence data) Monthly measles and rubella monitoring report (a concise report with TESSy data from 1 November 2016 – 31 October 2017) Bi-annual measles and rubella monitoring report (an extensive report, TESSy and epidemic intelligence data presented, with data from 1 January 2016 – 30 June 2017) ECDC Atlas of Infectious Diseases (TESSy data) Monthly-Measles-Rubella-monitoring-report-December-2017_0.pdf
  6. The Confederation of Meningitis Organisations (CoMO) are pleased to share the new: Vaccines Question & Answer Resource! This resource answers many of the more challenging questions surrounding vaccines including the topics of: Vaccine Manufacture and Availability Vaccine Protection Vaccine Safety View online>> Download PDF>> Please share this resource as far and wide as you consider appropriate within your professional and personal networks alike. Use the link: http://bit.ly/VaxQandA and the hashtag: #VaccinesWork CoMO's Vaccines Q&A Resource.pdf
  7. until
    Cognizance Scientific warmly welcomes all participants across the globe to attend Global Congress on Vaccine and Vaccination Techniques is going to be held at Dubai, during April 16-18,2018. Vaccine congress is mainly focused on “Vaccines research and Advance approach towards vaccination techniques for global cause” and its agenda is to produce high quality current research and best practices highlighted keynote presentations, oral and posters abstracts. Vaccine congress gathers diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. This global platform brings experts, Scientists, research scholars, academic and industry professionals to explore their work and enhance their skills for the improvement of our Scientific Community. Cognizance Scientific also provides an international exposure for young researchers and scholars through their research work by meeting expertise within the field of vaccines and enhancing their knowledge. The Conference comprises with symposium, workshops, Exhibitions, Young research forum, Poster sessions, renowned speakers and eminent keynote presentations. The global vaccines market is expected to grasp USD 48.03 Billion by 2021 from USD 32.24 Billion in 2017 at a CAGR of 8.3% from 2017 to 2021. The major factor driving the growth of this market are high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs Vaccine 2018 Brochure.pdf
  8. I conducted a small study in one rural area in the USA where patients have no-to-low science literacy. Among the elders, neither videos nor texts essays succeeded in withdrawing their interest to learn about viral diseases. BUT a comic book did that and more! To my knowledge, this is the first report on improving health education among old patients using comics. I’d love to see if such results are reproducible elsewhere in EU or the USA …. If someone is interested in making our small sample size bigger, that would be awesome!
  9. CAN YOU DESCRIBE THIS MAP IN ONE WORD? I have been asking this over the Social Media on Tiwtter - LinkedIn ...etc. Answers came as: DISTRUST - DEPRESSING - NO! - .... I'm curious to have more answers for this increasing vaccine hesitancy problem. Thank you, Susan
  10. Results of ECDC Survey Report on Immunisation Information Systems Introduction Strong information systems to digitally record information about vaccination, Immunisation Information Systems (IIS), are an integral part of a well-functioning vaccine programmes. This is recognised by the World Health Organisation’s European Vaccines Action Plan (EVAP) and further endorsed by the 2014 EU Council Conclusions on vaccination as an effective tool in public health. As part of its activities in support of the establishment of IIS in the EU/EEA Member States, ECDC has developed 2 surveys on IIS status and functionalities: (1) a comprehensive survey for countries with an established IIS; and (2) a shorter survey for countries in the early stages of implementation. The ECDC Survey Report on IIS presents the results providing information on the status of IIS in the EU/EEA countries and describes their functionalities. This information is particularly important for countries that have no system, are in the beginning stages of implementation or are updating their systems. 27 of the 30 EU/EEA countries responded the ECDC surveys, including 16 responses received to the comprehensive survey. 21 countries have an IIS or a pilot IIS in place, of which 14 countries have a national system or pilot in place and 7 countries have a sub-national system or pilot in place. Headline results (relating to the 16 countries that responded to the comprehensive survey) Where possible, we have linked the headline results from the ECDC Survey Report to the key messages of the European Immunisation Week: · Automated reminders For programme monitoring purposes, IIS can be used to determine which vaccinations are due or overdue, generate reminder or recall for providers and vaccine recipients, and determine immunisation coverage levels. 5 countries can send vaccine recipients automated reminders through their IIS. · Requirement to record public and private vaccination data Vaccines may be administered by different providers including private as well as public sector. For example, there are variations in vaccines administered as part of an EU/EEA country’s routine national immunization schedules or in the case of travel vaccinations to protect against diseases that are not common in the country of residence. 8 countries are required by law to record public and private vaccination data in the IIS, while 4 countries are required to record public vaccination data. · Whole-of-life vaccination data Vaccines are not just for kids and can offer protection at all ages. Many adults may neither have had access to currently available vaccines as a child, nor developed immunity to the diseases through natural infection. For some, boosters are needed to maintain protection. Adults over the age of 50 may be eligible for several vaccines that prevent diseases of particular concern for older populations. 10 countries include whole-of-life vaccination data in their IIS, whereas 6 record vaccination up to 18 years of age only. · Individual access to information For vaccine recipients, the possibility to access vaccination records easily and print an immunisation history or certificate is an important tool for individuals to stay up to date on immunisation. Many adults may not have received immunisation as part of their country’s current routine immunization schedule and may be unsure of their vaccination status. 5 countries provide individual vaccine recipients or their guardians with access to their individual information in the IIS. IIS_Survey_report_2016_Final-250417_KOCB2.pdf e. Simple graphics, ECDC survey on IIS.pptx
  11. The ECDC catalogue of interventions to address vaccine hesitancy offers a collection of 40 interventions developed in various countries around the world in order to measure and address vaccine hesitancy. It showcases examples of practices that can serve as a bank of ideas and be adapted according to national and local needs and strategies. The catalogue is divided into two parts. First, it lists relevant interventions that focus on developing tools to measure the scope and scale of vaccine hesitancy in various populations. These diagnostic tools can then be used by public health professionals to inform the development of targeted interventions to address vaccine hesitancy. Second, it focuses on interventions designed to address or respond to vaccine hesitancy. This part is subdivided into three categories: individual-level interventions focusing on parents; individual-level interventions focusing on improving healthcare workers’ confidence and communication skills to respond to hesitant patients; and interventions focusing on responding to hesitancy at a community level. Examples of interventions measuring the scope and scale of hesitancy Global vaccine confidence index The aim of the Global Vaccine Confidence Index is to measure vaccine hesitancy and provide information about hesitant populations and the nature of their concerns. Information is gathered through a survey administered globally through a joint collaboration between Gallup International and the London School of Hygiene and Tropical Medicine Vaccine Confidence Project. It gives a comparable indication about populations’ trust in vaccines and what their concerns are. Questionnaire measuring vaccine hesitancy among general practitioners The aim of the questionnaire is to measure, and to some extent quantify, vaccine hesitancy among general practitioners (GPs). The questionnaire assesses perceptions about vaccines (risk, utility), recommended behaviours towards patients, personal vaccination behaviours, and confidence in various sources of information about the benefits and risks of vaccines. It was administered by telephone interviews. Examples of interventions addressing or responding to vaccine hesitancy Web-based MMR decision aid The aim of the web based decision aid is to empower parents to make informed decisions about vaccination against measles, mumps and rubella. It consists of a step-by-step guide including frequently asked questions and answers, numerical and graphic data comparing the potential risks of the MMR vaccine with the potential risks of contracting disease and clarifies options available. It also includes a clarifying values exercise where the user reviews the importance they place on advantages and disadvantages of vaccination. Framework for communicating with vaccine hesitant parents This communication framework aims to improve communication between clinicians and vaccine hesitant parents. It helps clinicians to tailor their conversations with patients and avoid confrontational arguments. It uses the principles of motivational interviewing, thereby guiding patients rather than directing them and focusing on developing an empathic relationship. This respectful, non-judgemental approach aims to build trust between vaccine-providers and their patients. The intervention has two different communication approaches for different types of vaccine hesitant parents. Catalogue-interventions-vaccine-hesitancy.pdf
  12. The European Medicines Agency supports the European Immunization Week 2017. As part of our Annual Report 2016 to be published in May this year, a doctor, a researcher, and a regulatory body’s representative shared their thoughts on vaccine hesitancy. Their main quotes are encompassed in a set of images published under Gallery -> 'EIW 2017 materials'. The .pdf version of the interview is attached to this topic. vaccines interview final.pdf
  13. European Medicines Agency

    EMA_EIW_quote3.jpg

  14. European Medicines Agency

    EMA_EIW_quote2.jpg

  15. European Medicines Agency

    EMA_EIW_quote1.jpg

  16. European Medicines Agency

    EMA_EIW_Interview_Vaccines_Hesitancy.PNG

    The European Medicines Agency supports the European Immunization Week 2017. As part of our Annual Report 2016 to be published in May this year, a doctor, a researcher and a regulatory body’s representative shared their thoughts on vaccine hesitancy.
  17. (Vaccine, 19 Jan 2017) Immunisation efforts save millions of lives every year, but vaccines hold the potential to deliver even greater health benefits for mankind. Vaccine research and development is highly complex, and it requires concerted public funding efforts to support. In this paper we discuss EU funding priorities and the resulting recent advancements in European vaccine research, and we lay out the EU strategy for aiding promising vaccine candidates to successfully reach the market. Read more
  18. Unlike most other vaccinations, the one for influenza needs to be take every year in order for it to be effective. This infographic answers the question Why? It talks about antigens and receptors so isn't pitching itself to the 5-sec-glance audience but to those with the curiosity (and need) to understand why this is the case. Would you be interested in translating or adapting it for your own use?We have adaptable files (Adobe Illustrator) available for exactly that purpose.Contact Health.Communication@ecdc.europa.eu to get those files or to find out more.

    © European Centre for Disease Prevention and Control, 2016

  19. Reaching and maintaining sufficiently high immunization coverage is not possible without the active support of health professionals. Unfortunately, many involved in vaccination are not sufficiently informed and may have doubts themselves about the safety or efficacy of the vaccines they are administering. To close this information gap, WHO and the European Society of Paediatric Infectious Diseases (ESPID) developed the Wiser Immunisers online course, which is now offered through the ESPID website. The course is set to begin for the third time on 17 October, and registration is open until 10 October. Course participants earn 12 EU CME credits, and their feedback following the first two runs of the course has been very positive. The ESPID online course on vaccination provides internet-based training on: vaccine-preventable diseases including clinical presentation, diagnosis, management, treatment, prognosis and public health implications vaccines and their side effects and contraindications communicating with patients and caregivers about vaccination, including addressing common misconceptions and tackling vaccine hesitancy. More information about the course and how to register is available on the ESPID website: http://www.espid.org/content.aspx?Group=education&Page=wiser immuniser online course Please pass this information on to individuals or groups who could benefit from learning or refreshing their knowledge about this important topic.
  20. http://www.who.int/bulletin/volumes/94/9/en/ Rabies vaccine stockpile: fixing the supply chain Bernadette Abela-Ridder,a Stephen Martin,b Gyanendra Gongalc & Dirk Engelsa The challenges of introducing a malaria vaccine For the first time a malaria vaccine is to be tested for possible inclusion in national immunization programmes. Malcolm Molyneux tells Fiona Fleck why governments may need to work hard to convince people of its benefits.
  21. Free Resource @YouTube Anti-Vax = Anti-Facts ( Playlist ) https://www.youtube.com/playlist?list=PLefPh1XlGcqNQmRfAAziO7kyfqP2TO4xT
×